• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

核受体共激活因子AIB1介导胰岛素样生长因子I诱导的人乳腺癌细胞表型变化。

The nuclear receptor coactivator AIB1 mediates insulin-like growth factor I-induced phenotypic changes in human breast cancer cells.

作者信息

Oh Annabell, List Heinz-Joachim, Reiter Ronald, Mani Aparna, Zhang Ying, Gehan Edmund, Wellstein Anton, Riegel Anna T

机构信息

Department of Oncology, Vincent T. Lombardi Cancer Center, Georgetown University, Washington, District of Columbia 20057, USA.

出版信息

Cancer Res. 2004 Nov 15;64(22):8299-308. doi: 10.1158/0008-5472.CAN-04-0354.

DOI:10.1158/0008-5472.CAN-04-0354
PMID:15548698
Abstract

The nuclear receptor coactivator AIB1 (amplified in breast cancer 1) is overexpressed in human breast cancers and is required for estrogen signaling. However, the role of AIB1 in breast cancer etiology is not known. Here, we show that AIB1 is rate-limiting for insulin-like growth factor I (IGF-I)-dependent phenotypic changes and gene expression in human breast cancer cells. Reduction of endogenous AIB1 levels by small interfering RNA in MCF-7 breast cancer cells prevented IGF-I-stimulated anchorage-independent growth by reducing IGF-I-dependent anti-anoikis. cDNA array and immunoblot analysis of gene expression revealed that reduction in AIB1 levels led to a significant decrease in the expression of several genes controlling the cell cycle and apoptosis. These AIB1-dependent changes were also observed in the presence of estrogen antagonist and were corroborated in the estrogen receptor-negative cell line MDA MB-231. AIB1 reduction decreased the expression of the IGF-I receptor and IRS-1 in MCF-7 but not in MDA MB-231 cells. IGF-I-stimulated activation of AKT was reduced by AIB1 small interfering RNA treatment, whereas mitogen-activated protein kinase (extracellular signal-regulated kinase 1/2) activation by IGF-I was unaffected. We conclude that AIB1 is required for IGF-I-induced proliferation, signaling, cell survival, and gene expression in human breast cancer cells, independent of its role in estrogen receptor signaling.

摘要

核受体辅激活因子AIB1(乳腺癌中扩增基因1)在人类乳腺癌中过表达,是雌激素信号传导所必需的。然而,AIB1在乳腺癌病因学中的作用尚不清楚。在此,我们表明AIB1对人乳腺癌细胞中胰岛素样生长因子I(IGF-I)依赖性表型变化和基因表达具有限速作用。通过小干扰RNA降低MCF-7乳腺癌细胞中内源性AIB1水平,可通过减少IGF-I依赖性抗失巢凋亡来阻止IGF-I刺激的非锚定依赖性生长。基因表达的cDNA阵列和免疫印迹分析表明,AIB1水平降低导致几个控制细胞周期和凋亡的基因表达显著下降。在存在雌激素拮抗剂的情况下也观察到了这些AIB1依赖性变化,并在雌激素受体阴性细胞系MDA MB-231中得到证实。AIB1减少降低了MCF-7细胞中IGF-I受体和IRS-1的表达,但在MDA MB-231细胞中未降低。AIB1小干扰RNA处理降低了IGF-I刺激的AKT激活,而IGF-I对丝裂原活化蛋白激酶(细胞外信号调节激酶1/2)的激活未受影响。我们得出结论,AIB1是人类乳腺癌细胞中IGF-I诱导增殖、信号传导、细胞存活和基因表达所必需的,与其在雌激素受体信号传导中的作用无关。

相似文献

1
The nuclear receptor coactivator AIB1 mediates insulin-like growth factor I-induced phenotypic changes in human breast cancer cells.核受体共激活因子AIB1介导胰岛素样生长因子I诱导的人乳腺癌细胞表型变化。
Cancer Res. 2004 Nov 15;64(22):8299-308. doi: 10.1158/0008-5472.CAN-04-0354.
2
Differential insulin-like growth factor I receptor signaling and function in estrogen receptor (ER)-positive MCF-7 and ER-negative MDA-MB-231 breast cancer cells.雌激素受体(ER)阳性的MCF-7和ER阴性的MDA-MB-231乳腺癌细胞中胰岛素样生长因子I受体信号传导及功能的差异
Cancer Res. 2001 Sep 15;61(18):6747-54.
3
Amplified in Breast Cancer Regulates Transcription and Translation in Breast Cancer Cells.乳腺癌中扩增的基因调控乳腺癌细胞的转录和翻译。
Neoplasia. 2016 Feb;18(2):100-10. doi: 10.1016/j.neo.2016.01.001.
4
AIB1/SRC-3 deficiency affects insulin-like growth factor I signaling pathway and suppresses v-Ha-ras-induced breast cancer initiation and progression in mice.AIB1/SRC-3缺陷影响胰岛素样生长因子I信号通路,并抑制v-Ha-ras诱导的小鼠乳腺癌起始和进展。
Cancer Res. 2004 Mar 1;64(5):1875-85. doi: 10.1158/0008-5472.can-03-3745.
5
Ribozyme targeting demonstrates that the nuclear receptor coactivator AIB1 is a rate-limiting factor for estrogen-dependent growth of human MCF-7 breast cancer cells.核酶靶向实验表明,核受体辅激活因子AIB1是雌激素依赖的人MCF-7乳腺癌细胞生长的限速因子。
J Biol Chem. 2001 Jun 29;276(26):23763-8. doi: 10.1074/jbc.M102397200. Epub 2001 Apr 27.
6
Progesterone receptor-B regulation of insulin-like growth factor-stimulated cell migration in breast cancer cells via insulin receptor substrate-2.孕激素受体-B通过胰岛素受体底物-2调节胰岛素样生长因子刺激的乳腺癌细胞迁移。
Mol Cancer Res. 2008 Sep;6(9):1491-8. doi: 10.1158/1541-7786.MCR-07-2173.
7
Phenotypic alterations in breast cancer cells overexpressing the nuclear receptor co-activator AIB1.过表达核受体共激活因子AIB1的乳腺癌细胞的表型改变
BMC Cancer. 2003 Sep 10;3:22. doi: 10.1186/1471-2407-3-22.
8
Epidermal growth factor receptor tyrosine phosphorylation and signaling controlled by a nuclear receptor coactivator, amplified in breast cancer 1.由核受体共激活因子1调控的表皮生长因子受体酪氨酸磷酸化及信号传导,该因子在乳腺癌中呈扩增状态 。
Cancer Res. 2007 Aug 1;67(15):7256-65. doi: 10.1158/0008-5472.CAN-07-1013.
9
The PI3K and AIB1 interaction is involved in estrogen treated breast cancer cells.PI3K与AIB1的相互作用参与雌激素处理的乳腺癌细胞。
Cell Mol Biol (Noisy-le-grand). 2018 May 15;64(6):65-70.
10
Overexpression of an N-terminally truncated isoform of the nuclear receptor coactivator amplified in breast cancer 1 leads to altered proliferation of mammary epithelial cells in transgenic mice.在乳腺癌1中扩增的核受体共激活因子N端截短异构体的过表达导致转基因小鼠乳腺上皮细胞增殖改变。
Mol Endocrinol. 2005 Mar;19(3):644-56. doi: 10.1210/me.2004-0106. Epub 2004 Nov 18.

引用本文的文献

1
AIB1/SRC-3/NCOA3 function in estrogen receptor alpha positive breast cancer.AIB1/SRC-3/NCOA3 在雌激素受体阳性乳腺癌中发挥作用。
Front Endocrinol (Lausanne). 2023 Aug 30;14:1250218. doi: 10.3389/fendo.2023.1250218. eCollection 2023.
2
Depletion of the Transcriptional Coactivator Amplified in Breast Cancer 1 (AIB1) Uncovers Functionally Distinct Subpopulations in Triple-Negative Breast Cancer.乳腺癌扩增转录共激活因子 1(AIB1)耗竭揭示三阴性乳腺癌中功能不同的亚群。
Neoplasia. 2019 Oct;21(10):963-973. doi: 10.1016/j.neo.2019.07.001. Epub 2019 Aug 19.
3
The PPARγ agonist efatutazone delays invasive progression and induces differentiation of ductal carcinoma in situ.
过氧化物酶体增殖物激活受体γ激动剂 efatutazone 可延迟导管原位癌的侵袭进展并诱导其分化。
Breast Cancer Res Treat. 2018 May;169(1):47-57. doi: 10.1007/s10549-017-4649-y. Epub 2018 Jan 19.
4
Overexpression of SRC-3 promotes esophageal squamous cell carcinoma aggressiveness by enhancing cell growth and invasiveness.SRC-3的过表达通过增强细胞生长和侵袭性促进食管鳞状细胞癌的侵袭性。
Cancer Med. 2016 Dec;5(12):3500-3511. doi: 10.1002/cam4.884. Epub 2016 Oct 26.
5
Endocrine resistance in breast cancer--An overview and update.乳腺癌中的内分泌耐药——综述与更新
Mol Cell Endocrinol. 2015 Dec 15;418 Pt 3(0 3):220-34. doi: 10.1016/j.mce.2015.09.035. Epub 2015 Oct 9.
6
Cell growth density modulates cancer cell vascular invasion via Hippo pathway activity and CXCR2 signaling.细胞生长密度通过Hippo信号通路活性和CXCR2信号传导调节癌细胞的血管侵袭。
Oncogene. 2015 Nov 26;34(48):5879-89. doi: 10.1038/onc.2015.44. Epub 2015 Mar 16.
7
Conditionally reprogrammed normal and transformed mouse mammary epithelial cells display a progenitor-cell-like phenotype.条件重编程的正常和转化小鼠乳腺上皮细胞表现出祖细胞样表型。
PLoS One. 2014 May 15;9(5):e97666. doi: 10.1371/journal.pone.0097666. eCollection 2014.
8
Regulation of HER2 oncogene transcription by a multifunctional coactivator/corepressor complex.多功能共激活因子/共抑制因子复合物对HER2癌基因转录的调控
Mol Endocrinol. 2014 Jun;28(6):846-59. doi: 10.1210/me.2013-1379. Epub 2014 Mar 28.
9
Research resource: loss of the steroid receptor coactivators confers neurobehavioral consequences.研究资源:类固醇受体共激活因子的缺失会带来神经行为方面的后果。
Mol Endocrinol. 2013 Oct;27(10):1776-87. doi: 10.1210/me.2013-1192. Epub 2013 Aug 8.
10
The nuclear coactivator amplified in breast cancer 1 maintains tumor-initiating cells during development of ductal carcinoma in situ.核共激活因子在乳腺癌 1 中扩增,在原位导管癌发展过程中维持肿瘤起始细胞。
Oncogene. 2014 Jun 5;33(23):3033-42. doi: 10.1038/onc.2013.263. Epub 2013 Jul 15.